c="the patient" 13:0 13:1||c="who" 13:14 13:14||c="she" 14:0 14:0||c="her" 15:0 15:0||c="she" 16:0 16:0||c="she" 18:3 18:3||c="her" 19:0 19:0||c="she" 20:0 20:0||c="her" 21:0 21:0||c="her" 21:15 21:15||c="she" 22:0 22:0||c="she" 24:0 24:0||c="she" 25:0 25:0||c="she" 26:0 26:0||c="her" 26:10 26:10||c="she" 27:0 27:0||c="her" 28:0 28:0||c="she" 29:0 29:0||c="she" 30:0 30:0||c="she" 34:0 34:0||c="she" 35:0 35:0||c="she" 36:0 36:0||c="her" 36:5 36:5||c="she" 37:0 37:0||c="she" 38:3 38:3||t="coref person"
c="type 1 diabetes mellitus" 13:9 13:12||c="her diabetes mellitus" 15:0 15:2||c="type 1 diabetes mellitus" 41:1 41:4||t="coref problem"
c="postcadaveric kidney transplantation" 13:18 13:20||c="her kidney transplantation" 21:15 21:17||c="her kidney transplant" 26:10 26:12||c="kidney transplantation" 42:8 42:9||t="coref treatment"
c="cadaveric pancreas transplantation" 11:0 11:2||c="cadaveric pancreas transplantation" 14:3 14:5||c="cadaveric pancreas transplantation" 24:2 24:4||c="cadaveric pancreas transplant" 40:3 40:5||t="coref treatment"
c="nephropathy" 15:9 15:9||c="end stage renal disease" 42:1 42:4||t="coref problem"
c="induction therapy" 25:2 25:3||c="thymoglobulin" 25:5 25:5||t="coref treatment"
c="a similar immunosuppressive regimen" 26:4 26:7||c="immunosuppressant medications" 37:8 37:9||t="coref treatment"
